###begin article-title 0
Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1
###end article-title 0
###begin p 1
Conceived and designed the experiments: AS MDW. Performed the experiments: AS SM SM RMR. Analyzed the data: AS SM MDW. Contributed reagents/materials/analysis tools: AS MDW. Wrote the paper: AS MDW.
###end p 1
###begin p 2
Apoptosis depends upon the activation of intracellular caspases which are classically induced by either an intrinsic (mitochondrial based) or extrinsic (cytokine) pathway. However, in the process of explaining how endotoxin activated monocytes are able to induce apoptosis of vascular smooth muscle cells when co-cultured, we uncovered a transcellular apoptosis inducing pathway that utilizes caspase-1 containing microvesicles. Endotoxin stimulated monocytes induce the cell death of VSMCs but this activity is found in 100,000 g pellets of cell free supernatants of these monocytes. This activity is not a direct effect of endotoxin, and is inhibited by the caspase-1 inhibitor YVADcmk but not by inhibitors of Fas-L, IL-1beta and IL-18. Importantly, the apoptosis inducing activity co-purifies with 100 nm sized microvesicles as determined by TEM of the pellets. These microvesicles contain caspase-1 and caspase-1 encapsulation is required since disruption of microvesicular integrity destroys the apoptotic activity but not the caspase-1 enzymatic activity. Thus, monocytes are capable of delivering a cell death message which depends upon the release of microvesicles containing functional caspase-1. This transcellular apoptosis induction pathway describes a novel pathway for inflammation induced programmed cell death.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 139 142 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Howard1">[1]</xref>
###xml 143 146 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Thornberry1">[3]</xref>
###xml 184 194 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 274 277 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Yuan1">[4]</xref>
###xml 279 282 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Alnemri1">[5]</xref>
###xml 612 615 609 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinon1">[6]</xref>
###xml 616 619 613 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Shaw1">[8]</xref>
###xml 833 836 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinon1">[6]</xref>
###xml 981 984 975 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Yamin1">[9]</xref>
###xml 985 989 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Elliott1">[12]</xref>
###xml 1256 1260 1247 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Gavrilin1">[13]</xref>
###xml 184 194 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
Caspase-1 was first described as the IL-1 converting enzyme responsible for processing and hence activating proIL-1beta to its active form [1]-[3]. However, its structural homology to C. elegans death genes prompted the discovery of a class of proteases now termed caspases [4], [5]. It is now recognized that caspase-1 regulation depends upon the assembly of a protein complex, now termed the inflammasome. This structure is centered upon the adapter molecule ASC and typically another member of the NOD-like receptor or RIG-I receptor family that is thought to provide an intracellular danger sensing function [6]-[8]. Sensing of danger signals, either from pathogens (pathogen associated molecular patterns, PAMPs), from exogenous agents like silica, or endogenous signals such as ATP and uric acid, induces inflammasome assembly [6]. This assembly autoactivates caspase-1 by a proximity mediated process with the resultant release from the cell of processed IL-1beta and IL-18 [9]-[12]. Interestingly, it is now generally recognized that with caspase-1 activation, not only is IL-1beta and IL-18 processed and released by these danger sensing macrophages, but many of the inflammasome components themselves are also released, notably caspase-1 and ASC [13].
###end p 4
###begin p 5
###xml 246 250 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
###xml 284 288 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Brennan1">[15]</xref>
###xml 289 293 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Cookson1">[17]</xref>
Although caspase-1 is generally categorized as an "inflammatory" caspase by virtue of its activation of IL-1beta and IL-18, it is now clear that caspase-1 also plays a role in certain forms of cell death, e.g. sepsis induced lymphocyte apoptosis [14] and bacterial induced pyroptosis [15]-[17]. In these caspase-1 mediated processes, the dying cell's endogenous caspase-1 serves as the executioner caspase. However, in the process of analyzing how monocytes induce cell death in a co-culture model, we uncovered a novel transcellular mechanism of caspase-1 mediated cell death.
###end p 5
###begin p 6
Monocytes sensing of danger signals induces the release of IL-1beta, caspase-1 and ASC. These molecules are released in microvesicle packets that have the capacity to deliver a cell death message to proliferating smooth muscle cells. This cell death message is dependent upon the catalytic function of caspase-1 and upon the integrity of the microvesicle capsules. This novel pathway of caspase-1 mediated cell death adds a novel twist to the characterized functions of caspase-1.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Contact independent apoptosis of vascular smooth muscle cells by monocytes
###end title 8
###begin p 9
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Ludewig1">[18]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Imanishi1">[21]</xref>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 465 474 461 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 465 474 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1A</bold></xref>
###xml 962 969 958 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 962 969 958 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t001"><bold>Table 1</bold></xref>
###xml 969 980 965 976 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Top panel</bold>
###xml 1103 1112 1099 1108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1103 1112 1099 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1C</bold></xref>
###xml 1158 1173 1154 1169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A and B</bold>
###xml 1158 1173 1154 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1A and B</bold></xref>
###xml 1576 1584 1572 1580 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 1576 1584 1572 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1</bold></xref>
Since monocytes take up residence with vascular smooth muscle cells (VSMCs) in atherosclerotic plaques [18]-[21], we used an in vitro co-culture model to analyze the monocyte ability to induce VSMC death. Vascular smooth muscle cells (VSMC) were cocultured with monocytes in the presence or absence of LPS (1 microg/ml) for 24 h. Monocytes stimulated with LPS induced significant VSMC cell death, as compared to VSMC cocultured with control unstimulated monocytes (Figure 1A). To determine whether this cell death induction of VSMC by monocytes was contact dependent, VSMC were cultured with conditioned medium from monocytes untreated or pretreated with LPS for 2 h. Cell survival was measured using crystal violet staining, total cell count under light microscope, Annexin V and caspase-3 activation assays. Conditioned medium from LPS treated monocytes resulted in significant VSMC cell death, whereas conditioned medium from control monocytes had no effect (Table 1, Top panel). Cell death was confirmed to be apoptosis as measured by classical apoptotic morphology of cells under light microscope (Figure 1C), Annexin V and caspase-3 activation assays (Figure 1A and B ). Apoptosis induction by monocytes was completely inhibited in the presence of the specific caspase-1 inhibitor, YVADcmk. Briefly, monocytes were pretreated with YVADcmk for 15 min, washed and then stimulated with LPS or left untreated for 2 h. Conditioned medium was then added to VSMC and effect on apoptosis was analyzed. YVADcmk completely abrogated apoptosis induced by LPS stimulated monocytes (Figure 1).
###end p 9
###begin title 10
VSMC apoptosis by monocytes is contact independent and inhibited by caspase-1 inhibitor.
###end title 10
###begin p 11
Monocytes were stimulated with LPS (1 microg/ml) for 15 min in the presence or absence of YVADcmk. VSMCs were either co-cultured with these monocytes or subjected to conditioned medium from the stimulated monocytes. Apoptosis was measured by A) Annexin/PI and B) caspase-3 assays along with C) morphology. D) Monocytes were also stimulated with LPS (1 microg/ml) for indicated time and IL-18 and IL-1beta release was measured from supernatants by ELISA. E) Supernatants were also analyzed for total and functional caspase-1 using ELISA and WEHD-assays. Cytokine and enzymatic assays depicted in graphs are based on average of n = 2 experiments.
###end p 11
###begin title 12
Induction of VSMC death.
###end title 12
###begin p 13
###xml 287 290 283 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">570</sub>
###xml 292 301 288 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Top Panel</bold>
###xml 385 397 381 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Second Panel</bold>
###xml 551 552 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 551 552 547 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>#</sup></bold>
###xml 566 577 562 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Third Panel</bold>
###xml 694 706 690 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bottom Panel</bold>
###xml 813 814 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">@</sup>
###xml 813 814 809 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>@</sup></bold>
###xml 837 838 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">$</sup>
###xml 837 838 833 834 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>$</sup></bold>
ˆCell death of VSMC was measured at 18 h after treatments as outlined. Monocyte supernatants or MVs were all generated by 15 min. incubations with LPS (1 microg/ml). Vascular smooth muscle cell death was inversely related to the crystal violet staining of resident cells as measured at A570. Top Panel, VSMC death by conditioned medium from LPS stimulated monocytes (*LPS vs control); Second Panel, Inhibition of VSMC death by MV isolated from LPS treated monocytes that had been pretreated with the caspase-1 inhibitor, YVAD (*Treatments vs control, #YVAD vs LPS); Third Panel, VSMCs were pretreated with different inhibitors for 30 mins before being subjected to MV (*Inhibitors vs control); Bottom Panel, Effect of homogenization or heat-inactivation of MV before addition to VSMC (* Different MVs vs control, @homogenized vs intact, $heat inactivated vs intact).
###end p 13
###begin title 14
Cytokines and active caspase-1 release by LPS-stimulated monocytes
###end title 14
###begin p 15
###xml 332 341 323 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 332 341 323 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1D</bold></xref>
###xml 674 683 662 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 674 683 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1E</bold></xref>
###xml 813 822 801 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 813 822 801 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g001"><bold>Figure 1E</bold></xref>
Conditioned medium from monocytes was analyzed for the presence of IL-1beta and IL-18 by ELISA. Upon stimulation with LPS, monocytes released both mature IL-1beta and IL-18 into the supernatant. IL-18 was measured in the medium as early as 15 min after LPS challenge. IL-1 beta became detectable at 1 h and reached a peak at 2-3 h (Figure 1D). Release of both mature IL-18 and IL-1 beta was completely abrogated in the presence of the caspase-1 inhibitor, YVADcmk. Caspase-1 was also identified in the supernatants of stimulated monocytes. Active caspase-1 was released as early as 15 min from LPS stimulated monocytes and this release increased in a time dependent manner (Figure 1E). That the released caspase-1 from LPS stimulated cells was active was confirmed by both immunoblot and WEHDafc enzymatic assay (Figure 1E).
###end p 15
###begin title 16
Microvesicular release of active caspase-1 and ASC by LPS-stimulated monocytes
###end title 16
###begin p 17
###xml 223 227 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Hugel1">[22]</xref>
###xml 228 232 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Qu1">[29]</xref>
###xml 615 624 608 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 615 624 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g002"><bold>Figure 2A</bold></xref>
###xml 624 627 617 620 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 627 634 620 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 627 634 620 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t002"><bold>Table 2</bold></xref>
###xml 778 787 771 780 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 778 787 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g002"><bold>Figure 2B</bold></xref>
###xml 1068 1075 1061 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 1068 1075 1061 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t003"><bold>Table 3</bold></xref>
###xml 1326 1335 1319 1328 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 1326 1335 1319 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g002"><bold>Figure 2C</bold></xref>
###xml 1335 1336 1328 1329 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1602 1611 1595 1604 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 1602 1611 1595 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g002"><bold>Figure 2C</bold></xref>
###xml 1875 1882 1868 1875 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 1875 1882 1868 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t004"><bold>Table 4</bold></xref>
###xml 2232 2241 2225 2234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 2232 2241 2225 2234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g002"><bold>Figure 2C</bold></xref>
We next examined the mode of release of active caspase-1 from stimulated monocytes freshly isolated from buffy coats. Microvesicle shedding is a recognized mode of cytokine release, as described for IL-1beta and Fas ligand [22]-[29]. To examine the possibility of microparticle/microvesicle release microvesicles were isolated from unstimulated and LPS challenged fresh monocytes by ultracentrifugation. Isolated microvesicles were then quantified by flow cytometry. Stimulated monocyte microvesicles were enriched for smaller vesicles (i.e. <0.2 microm), 50.4% versus 9.3% for unstimulated monocyte microvesicles (Figure 2AandTable 2). Isolated microvesicles were also characterized by transmission electron microscopy. The LPS induced microvesicles were less than 0.1 micron (Figure 2B) by comparison to calibrated beads. That this microvesicle release by monocytes upon stimulation by LPS was not the effect of monocyte cell death was confirmed by analyzing the stimulated monocytes for cell death using Annexin/PI assay and LDH measurements from the supernatants (Table 3). These microvesicles were then subjected to immunoblot analysis for the presence of caspase-1 and ASC. Active microvesicular caspase-1 was shed from monocytes stimulated with LPS in a time dependant manner, as early as 15 min after LPS stimulation (Figure 2C). This release of active caspase-1 in vesicles correlated with our earlier observation of active caspase-1 in the supernatants of monocytes stimulated for 15 min. That caspase-1 released in the vesicle was active was also confirmed by WEHDafc assay of the vesicles (Figure 2C). Caspase-1 release in MVs was also quantified, over time after LPS challenge, and compared to the amounts of caspase-1 in the cells. Approximately 15% of caspase-1 was released by the monocytes packaged in microvesicles as early as 15 min after LPS stimulation (Table 4). Monocytes pretreated with caspase-1 inhibitor, YVADcmk also released caspase-1 in vesicles upon stimulation, but in an inactive-proform. Microvesicles also contained the inflammasome protein ASC, critical for caspase-1 activation. ASC, similar to caspase-1, was identified both in the supernatants and microvesicles from LPS stimulated monocytes (Figure 2C).
###end p 17
###begin title 18
Active caspase-1 release from stimulated monocytes occurs in microvesicles.
###end title 18
###begin p 19
Monocytes were stimulated with LPS (1 microg/ml) for 15 min. Microvesicles were isolated from LPS stimulated monocytes supernatant by ultracentrifugation. Isolated microvesicles were analyzed by A) flow cytometry and B) transmission electron microscopy. C) Microvesicles were further analyzed for presence of catalytically active caspase-1 and inflammasome protein, ASC, by immunoblot. Activity of caspase-1 was also measured using WEHD-enzymatic assay. Immunoblots are representative of n = 3 experiments and caspase-1 enzymatic assay is average of n = 2 experiments.
###end p 19
###begin title 20
Monocyte microvesicle quantitation by flow cytometry.
###end title 20
###begin p 21
ˆEvents were quantified for 10,000 flow events of vesicles both <0.2 and >0.2-<1.0 microns from monocytes either untreated or stimulated with LPS (1 microg/ml) for 15 minutes. Data from n = 3 experiments.
###end p 21
###begin title 22
Microvesicle release by stimulated monocytes is independent of cell death.
###end title 22
###begin p 23
ˆMonocytes were analyzed for cell death after stimulation with LPS for different periods of time. Annexin V assay (n = 2 experiments) and LDH (n = 3 experiments).
###end p 23
###begin title 24
Quantification of caspase-1 release in microvesicles.
###end title 24
###begin p 25
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
ˆMonocytes (107/ml) were stimulated with LPS for indicated time and MVs were isolated from the supernatant. Cell lysates (CE) and MVs isolated from the supernatant were quantified for caspase-1 using ELISA.
###end p 25
###begin title 26
Monocyte microvesicular caspase-1 induces VSMC apoptosis
###end title 26
###begin p 27
###xml 507 514 507 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 507 514 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t005"><bold>Table 5</bold></xref>
###xml 514 529 514 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Panel 1 and 2</bold>
###xml 614 621 614 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 614 621 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t005"><bold>Table 5</bold></xref>
###xml 621 630 621 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Panel 3</bold>
###xml 716 723 716 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 716 723 716 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t005"><bold>Table 5</bold></xref>
###xml 723 732 723 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Panel 4</bold>
Vascular smooth muscle cells were then co-cultured with microvesicles isolated from conditioned medium of either unstimulated monocytes or monocytes stimulated with LPS for different periods of time. Monocytes used in all experiments were freshly isolated from buffy coats. Cell death of VSMCs was analyzed using Annexin V and crystal violet assays. Microvesicles isolated from as early as 15 min of LPS stimulation to monocytes induced approximately 43% cell death of VSMC as compared to control vesicles (Table 5, Panel 1 and 2). Active caspase-1 was encapsulated in the microvesicles as observed by WEHD assay (Table 5, Panel 3). Increased caspase-3 activity was also observed in VSMCs upon cell death induction (Table 5, Panel 4).
###end p 27
###begin title 28
Time course of VSMC cell death by MV.
###end title 28
###begin p 29
###xml 185 194 185 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Panel 1)</bold>
###xml 225 234 225 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Panel 2)</bold>
###xml 255 264 255 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Panel 3)</bold>
###xml 288 297 288 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Panel 4)</bold>
ˆMonocytes were stimulated with LPS for indicated period of time and microvesicles (MV) were isolated. MVs were then subjected to VSMC and analyzed for cell death using Annexin-V assay (Panel 1) and Crystal violet (CV) assay (Panel 2). Caspase-1 activity (Panel 3) and caspase-3 activity (Panel 4) were measured from MVs and VSMCs respectively. Annexin-V and caspase -1 and 3 assays represented here are average of N = 2 experiments. CV assay is representative of N = 4 experiments.
###end p 29
###begin p 30
###xml 334 343 334 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 334 343 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g003"><bold>Figure 3A</bold></xref>
###xml 452 461 452 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g003"><bold>Figure 3B</bold></xref>
###xml 461 464 461 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 464 471 464 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 464 471 464 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t001"><bold>Table 1</bold></xref>
###xml 471 485 471 485 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Second panel</bold>
###xml 663 672 663 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 663 672 663 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g003"><bold>Figure 3C</bold></xref>
###xml 1225 1234 1225 1234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 1225 1234 1225 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g003"><bold>Figure 3D</bold></xref>
###xml 1234 1237 1234 1237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</bold>
###xml 1237 1244 1237 1244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1237 1244 1237 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t001"><bold>Table 1</bold></xref>
###xml 1244 1257 1244 1257 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Third panel</bold>
To test the involvement of encapsulated caspase-1 in vesicles in VSMC cell death induction, MVs were isolated from monocytes either pretreated or not with caspase-1 inhibitor, YVADcmk prior to LPS challenge for 15 min. Increased cell death of VSMC (approximately 40%) was observed as compared to vesicles from unstimulated monocytes (Figure 3A). Vesicles from monocytes pretreated with YVADcmk before LPS challenge were unable to induce death of VSMC (Figure 3BandTable 1, Second panel), suggesting the possible role of caspase-1 or its substrate in the induction of VSMC cell death. The non-vesicular fractions did not induce killing of the smooth muscle cells (Figure 3C). To further investigate the possibility of caspase-1 and other caspase involvement in this cell death induction, VSMCs were pretreated with YVAD (caspase-1 inhibitor), DEVD (caspase-3 inhibitor) and ZVAD (pan-caspase inhibitor) before being subjected to MVs isolated from monocytes stimulated with LPS for 15 min. Cell death was measured after 18 h. All caspase inhibitors were capable of inhibiting induction of VSMC cell death. YVAD abrogated approximately 50% of cell death induced by MVs, whereas DEVD and ZVAD prevented 70% and 90% respectively (Figure 3DandTable 1, Third panel).
###end p 30
###begin title 31
Microvesicles released by LPS- stimulated monocytes induce VSMC apoptosis.
###end title 31
###begin p 32
Monocytes were stimulated with LPS (1 microg/ml) for 15 min and microvesicles were isolated from supernatant by ultracentrifugation. VSMCs were then treated with microvesicles isolated from unstimulated, LPS, and LPS + YVAD treated monocytes. Cell death was measured by Annexin V/PI assays using flow cytometry. A) Representative data of apoptosis of VSMC by flow cytometry using Annexin V/PI assay. B) Average of quantitative analysis of the same (n = 2); C) VSMCs were pretreated with specific caspase inhibitors, YVAD (casp-1inhibitor), DEVD (casp-3 inhibitor) and ZVAD (pan-caspase inhibitor). MVs were isolated from monocytes stimulated with LPS for 15 min and subjected to the pretreated VSMCs for 18 h. Cell death was analyzed by Annexin V/PI assays (n = 2); D) Monocytes were again stimulated with LPS (1 microg/ml) for 15 min and both microvesicles (MV) and the non-vesicular fractions (non-MV) were isolated from supernatant of monocytes using ultracentrifugation. Both microvesicle (MV) and non-microvesicle (non-MV) fractions were subjected to VSMC and apoptosis was analyzed using Annexin V/PI assays.
###end p 32
###begin p 33
###xml 1071 1080 1065 1074 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 1071 1080 1065 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g004"><bold>Figure 4A</bold></xref>
To test if the LPS-induced monocyte-specific killing of smooth muscle cells was directly due to the exogenous caspase-1, as opposed to its products, we used blocking reagents to common cytokines released by monocytes upon LPS challenge (IL-18 and IL-1beta) as well as Fas ligand to then monitor VSMC killing. Briefly, monocytes were pretreated with specific caspase-1 inhibitor (YVADcmk) or DMSO for 30 min. Monocytes were then washed with PBS to remove the remaining inhibitor. VSMC cells were also pretreated with IL-1 receptor antagonist (IL-1RA), IL-18 binding protein (IL-18BP), soluble Fas ligand or saline (as control) for 30 min. Monocytes were then stimulated with LPS for 15 min and microvesicles were isolated from the conditioned medium. Pretreated VSMCs were then subjected to these microvesicles (as described earlier) and analyzed for cell death. VSMC death was abrogated only by pretreatment with the specific caspase-1 inhibitor, YVADcmk. Inhibiting IL-18, IL-1beta or FAS did not significantly affect the killing of VSMC, as compared to saline control (Figure 4A). We also performed experiments stimulating vascular smooth muscle cells with LPS, rIL-18, IL-1beta or soluble FasL directly for 24 h. Direct stimulation of smooth muscle cells with these stimuli did not induce VSMC apoptosis.
###end p 33
###begin title 34
Microvesicle encapsulated exogenous caspase-1 directly induces VSMC apoptosis.
###end title 34
###begin p 35
A) Monocytes were either pretreated with YVAD-cmk or DMSO for 30 min. Cells were then rinsed with PBS and then stimulated with LPS (1 microg/ml) for 15 min. Microvesicles were isolated from the conditioned medium. Additionally, VSMCs were also pretreated with either saline, or with IL-1RA, IL-18 bp or sFAS for 30 min (* indicates VSMC pretreatments). VSMCs were then subjected to the isolated microvesicles from LPS stimulated monocytes. (blacksquare, square, filled) VSMC+ MV from control monocytes; () VSMC+ MV from LPS/YVAD monocytes; () VSMC treated with IL-1RA+ MV from LPS treated monocytes; (square) VSMC treated with IL-18 bp + MV from LPS treated monocytes; () VSMC treated with sFAS+ MV from LPS treated monocytes. Apoptosis of VSMC was measured using Annexin V/PI assay. Graph represents average of n = 2 experiments. B) HEK-293 cells were transfected with either wild type or mutant caspase-1 (0.2 microg) along with ASC (0.2 microg) using Lipofectamine 2000. Transfection was normalized using vector controls. Supernatants were collected from the transfected cells and subjected to VSMC. Apoptosis was measured using Annexin V/PI assays. THP-1 cells were lysed and cell lysates were either kept at 4degreesC or incubated at 30degreesC for 1 h. Cell lysates were then centrifuged at 15,000 X g for 20 min. Both lipid and non-lipid fractions were measured for caspase-1 activity using C) immunoblot and D) WEHD-enzymatic assay. E) Both fractions were also subjected to VSMC and cell death was analyzed by Annexin V/PI assays.
###end p 35
###begin p 36
###xml 918 927 918 927 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 918 927 918 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g004"><bold>Figure 4B</bold></xref>
As an alternate approach to confirm the specific role of exogenous active caspase-1 in inducing smooth muscle death, plasmids expressing EGFP tagged pro-caspase-1 (both cysteine wildtype and mutant) were expressed in HEK293 cells along with the inflammasome protein ASC. ASC is capable of activating the wild type caspase-1 but not the cysteine active site mutant of caspase-1. Expression patterns of wild type and mutant caspase-1 as well as ASC in HEK293 cells were confirmed by immunoblot. Activity of caspase-1 upon transfection was also confirmed by enzymatic assay and immunoblotting (data not shown). Smooth muscle cells were then cultured in conditioned medium from both active and mutant caspase-1 transfected cells. Conditioned medium containing wildtype active caspase-1 was capable of inducing apoptosis but the mutant form was not, confirming the specific role of active caspase-1 in inducing cell death (Figure 4B).
###end p 36
###begin p 37
###xml 290 295 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 295 299 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Kahlenberg1">[30]</xref>
###xml 414 423 396 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 414 423 396 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g004"><bold>Figure 4C</bold></xref>
###xml 479 488 461 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 479 488 461 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g004"><bold>Figure 4D</bold></xref>
###xml 826 835 796 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 826 835 796 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g004"><bold>Figure 4E</bold></xref>
This novel role of caspase-1 was further confirmed by using a THP-1 derived cell free system. Cell free extracts from THP-1 cells were incubated either at 4degreesC or 30degreesC for 1 h and then subjected to centrifugation at 10,000xg following the caspase-1 activation protocol of Dubyak et al[30]. Active caspase-1 was identified only in the lipid layer of the cell free extract after incubation at 30degreesC (Figure 4C). Activity was also confirmed using WEHD-afc cleavage (Figure 4D). The lipid layer exhibited a significant amount of caspase-1 activity when compared to non-lipid fractions. When smooth muscle cells were incubated with either the lipid or non-lipid extract of THP-1 either kept at 4degreesC or incubated at 30degreesC, only lipid fractions having active caspase-1 induced smooth muscle cell apoptosis (Figure 4E).
###end p 37
###begin title 38
Encapsulation is necessary for exogenous caspase-1 induced cell death
###end title 38
###begin p 39
###xml 804 814 786 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A)</bold>
###xml 804 814 786 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g005"><bold>Figure 5A)</bold></xref>
###xml 1046 1053 1028 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1046 1053 1028 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007140-t001"><bold>Table 1</bold></xref>
###xml 1053 1067 1035 1049 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, Bottom panel</bold>
###xml 1497 1506 1479 1488 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 1497 1506 1479 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007140-g005"><bold>Figure 5B</bold></xref>
Finally, we examined the role of encapsulation in the cell death induced by exogenous caspase-1. Since caspase-1 release from stimulated monocytes was contained in microvesicles, we asked whether this encapsulation was critical for the cell death induction. To test this hypothesis, microvesicles derived from LPS stimulated monocytes (as described previously) were either kept intact or subjected to disruption (15 strokes on ice) or heat-inactivation (incubated at 65degreesC for 10 min). VSMCs were then cocultured with these vesicles and analyzed for cell death by Annexin V and crystal violet assays. Intact microvesicles from LPS stimulated monocytes induced significant VSMC cell death (approximately50% as compared to cells exposed to vesicles shed by unstimulated monocytes by Annexin V assay) (Figure 5A). The crystal violet assay demonstrated a similar trend of cell death; VSMCs treated with intact microvesicles exhibited approximately 50% cell death as compared to 2-10% by homogenized and heat inactivated microvesicle treatments (Table 1, Bottom panel). In contrast, cell death was completely abrogated in cells exposed to both ruptured and heat-inactivated microvesicles. Intact, homogenized and heat-inactivated microvesicles were then analyzed for caspase-1 activity using both immunoblot and enzymatic assay systems. Both intact and homogenized microvesicles contained active caspase-1, whereas the caspase-1 activity was completely lost by heat-inactivation of microvesicles (Figure 5B).
###end p 39
###begin title 40
Vesiculation is necessary for exogenous caspase-1 mediated apoptosis of VSMC.
###end title 40
###begin p 41
Monocytes were either stimulated with LPS (1 microg/ml) for 15 min, 30 min, 1 h and 2 h or left untreated prior to microvesicles isolation. Microvesicles were then either kept intact or disrupted by mild homogenization or subjected to heat inactivation of encapsulated caspase-1. A) Microvesicles isolated from different times of LPS stimulation were then subjected to VSMC for 18 h and induction of apoptosis of VSMC was analyzed by Annexin V/PI assay. B) Caspase-1 activity of each fraction was measured using WEHD enzymatic assay. Time (h) in the figure indicates time of LPS stimulation of monocytes prior to MV isolation.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 98 101 98 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Yuan1">[4]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Steller1">[31]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Elkon1">[33]</xref>
###xml 392 396 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
###xml 397 401 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Cookson1">[17]</xref>
###xml 480 484 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
Executioner caspases such as caspases 3, 6 and 7 are recognized mediators of apoptotic cell death [4], [31]-[33], whereas caspase-1 is the prime member of the inflammatory caspase family which functions to activate proIL-1beta and proIL-18. Nevertheless, caspase-1 clearly can contribute to cell death as has been described for macrophages responding to intracellular pathogens in pyroptosis [14]-[17] and as we have shown for splenic B lymphocyte apoptosis in response to sepsis [14]. However, that caspase-1 might be released from one cell to induce the cell death of a bystander cell has not been previously described. It is in this context that we here describe a novel pathway of caspase-1 mediated cell death. Monocytes induced by endotoxin are capable of releasing caspase-1 encapsulated in microvesicles that has the capacity to target an external cell, in this case proliferating vascular smooth muscle cells, for programmed cell death.
###end p 43
###begin p 44
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Ludewig1">[18]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Imanishi1">[21]</xref>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
VSMC apoptosis occurs in all stages of atherosclerosis and is triggered by a combination of factors and conditions [18]-[21]. Because monocytes are the key inflammatory cells present in atherosclerotic plaques, we hypothesized that monocytes might provide the stimulus for VSMC apoptosis. We reasoned that this apoptotic event may be a critical component of atherosclerotic plaque rupture. We therefore developed an in vitro model of VSMC monocyte interactions to study potential mechanisms of the apoptotic event. Our findings document for the first time the novel role of monocyte-derived, microvesicular caspase-1 in the induction of VSMC apoptosis. Whereas monocytes cocultured with VSMC induced no significant cell death, remarkable VSMC death was induced by LPS treatment of the cocultures or when VSMCs were cocultured with conditioned medium from monocytes stimulated with LPS. Importantly, LPS in the absence of monocytes did not induce VSMC death. This apoptosis was completely abrogated when monocytes were pretreated with a specific caspase-1 inhibitor, YVADcmk.
###end p 44
###begin p 45
Since it is generally believed that caspase-1's apoptotic function involves an enzymatic cleavage of cytosolic substrates, we wondered whether the cell death inducing activity from monocytes was packaged in vesicles. That is, encapsulation of caspase-1 would provide a means for both protecting the caspase-1 prior to cytosolic delivery and allowing its entry into the cytosol of targeted cells. Our findings support the concept that monocytes release microvesicles which carry active caspase-1 into the cytosol of targeted smooth muscle cells and induce apoptosis. We believe that our studies are the first to test this hypothesis.
###end p 45
###begin p 46
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Distler1">[23]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-McKechnie1">[25]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinez1">[34]</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Watanabe1">[35]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Distler1">[23]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinez1">[34]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Boyle1">[36]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Boyle1">[36]</xref>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Microvesicles have been known to be shed by cells during activation or apoptosis and to carry different factors and proteins. Monocyte/macrophage derived MVs have been reported to transport biologically significant amounts of phosphatidylserine and tissue factor [23]-[25], [34], [35]. Of note, monocyte/macrophage derived MVs have been found in human atherosclerotic lesions [23], [34], [36]. Furthermore, caspase-1 has also been reported to be enhanced in the plaque regions associated with an increase in infiltration of monocytes and macrophages [36].
###end p 46
###begin p 47
###xml 585 589 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Carta1">[26]</xref>
###xml 590 594 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Qu1">[29]</xref>
Whether this encapsulation of active caspase-1 is important in the actual events related to plaque rupture remain to be shown. However, our data provide clear evidence to support the packaging of exogenous caspase-1 into microvesicles. These particles have the potential to contribute to smooth muscle cell death in plaques. Interestingly, the release of caspase-1 in vesicles parallels what we know about the release of the caspase-1 substrates IL-1beta and IL-18. IL-1beta release has been hypothesized to occur in the form of small packages termed microvesicles or vesicular bodies [26]-[29]. It is therefore, reasonable to hypothesize that caspase-1 release from cells might also require vesiculation. In this context, the present study confirms that active caspase-1 is released by activated monocytes in microparticles less than 0.1 microm and that this encapsulation is critical for its apoptotic function. Support for the need for caspase-1 encapsulation derives from our finding that mechanical disruption of microvesicles completely abrogates their apoptotic potential.
###end p 47
###begin p 48
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Yuan1">[4]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Cookson1">[17]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Miura1">[37]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Friedlander1">[40]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Wang1">[39]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Friedlander1">[40]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Fahy1">[41]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Gagliardini1">[42]</xref>
###xml 879 884 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-VanDerVelden1">[43]</xref>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-VanDerVelden1">[43]</xref>
###xml 1275 1279 1275 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
###xml 1281 1285 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Fahy2">[44]</xref>
###xml 658 661 <span type="species:ncbi:10116">rat</span>
###xml 733 736 <span type="species:ncbi:9913">cow</span>
Members of the caspase-related protease family have been shown to play an important role in apoptosis [4], [14]-[17], [37]-[40]. However the specific role of caspase-1 in apoptosis is controversial. Caspase-1 knockout animals are born healthy without detectable morphological abnormalities, whereas caspase-3 deficient animals have major birth defects, particularly neurological defects which imply a role for caspase-3 in developmental apoptosis [39], [40]. Furthermore, we have previously documented that spontaneous monocyte apoptosis is not dependent upon caspase-1 but upon caspase-3 activity [41]. On the other hand, over expression of caspase-1, in a rat fibroblast cell line, induces an apoptosis which is blocked by crmA, a cow pox virus protein that inhibits caspase-1 [42]. The involvement of caspase-1 in neuronal cell apoptosis is also well established. Gagliardini et al, 1994, observed the ability of a caspase-1 inhibitor to prevent apoptosis induced by nerve growth factor deprivation [43]. Furthermore, caspase-1 has been implicated in the death of Salmonella infected dendritic cells and monocyte derived macrophages [43]. Work from our own laboratory has shown the unique role of caspase-1 in regulating sepsis survival by regulating lymphocyte apoptosis [14], [44]. Thus, the present work lends support to the notion that caspase-1 is important in at least selected forms of programmed cell death. Our findings suggest that caspase-1 directly regulates the apoptosis of smooth muscle cells and that encapsulation of this active caspae-1 in microvesicles is critical for its function.
###end p 48
###begin p 49
###xml 333 337 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar1">[14]</xref>
###xml 339 343 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Fahy2">[44]</xref>
###xml 345 349 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Casey1">[45]</xref>
Other potential mechanisms to explain the VSCM apoptosis by the monocyte product include the concomitant release of potent cytokines. Caspase-1 is known to be principally responsible for the production of mature IL-1beta and IL-18 from their precursor forms. These inflammatory cytokines have been linked to organ injury and failure [14], [44], [45]. However, in this context, we found no statistical difference between apoptosis of smooth muscle cells that were subjected to conditioned medium after blockade of both IL-1beta and IL-18.
###end p 49
###begin p 50
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinon1">[6]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinon2">[46]</xref>
###xml 440 443 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Martinon1">[6]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Shaw1">[8]</xref>
###xml 750 754 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar2">[47]</xref>
###xml 756 760 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Kobayashi1">[48]</xref>
###xml 900 904 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Sarkar2">[47]</xref>
Lastly, and perhaps linked to the apoptosis concept, is the possibility that caspase-1 has important effects on the host intracellular defense system. This idea is supported by the growing body of evidence that places caspase-1 at the center of complex of regulatory proteins termed the inflammasome [6], [46]. It is believed that caspase-1 interacts with various members of these novel molecules via its caspase recruitment domain or CARD [6]-[8]. It is likely that caspase-1 may play a central role in the structural integrity, organization and/or regulation of these intracellular protein complexes. For example, caspase-1 is known to interact with RIP2, a kinase that is important in upstream activation of NF-kappaB, via CARDs on both molecules [47], [48]. We have recently demonstrated that caspase-1 may also function as a scaffolding molecule that promotes RIP2 mediated NF-kappaB activation [47].
###end p 50
###begin p 51
In summary, our results demonstrate that caspase-1 plays a central role in the regulation of apoptosis. This novel apoptotic event is dependent upon encapsulation of exogenous caspase-1 into released microvesicles that allow targeting of the active enzyme to the cytosol of different cells, in this study vascular smooth muscle cells. Future studies will need to determine whether this mechanism is targeted to specific cells or acts via a concentration dependent stochastic process.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Reagents
###end title 53
###begin p 54
###xml 36 52 <span type="species:ncbi:562">Escherichia coli</span>
###xml 237 243 <span type="species:ncbi:9913">bovine</span>
Bacterial lipopolysaccharide (LPS), Escherichia coli strain 0127:B8, Westphal preparation, was obtained from Difco (Detroit, MI). RPMI 1640 and phosphate buffered saline (PBS) was purchased from BioWhitaker (Walkersville, MD), and fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT). The pan-caspase inhibitor, z-Val-Ala-Asp (O-Methyl) fluoromethyl ketone (zVADfmk) and inactive caspase inhibitor, z-Phe-Ala-fluoromethylketone (zFAfmk) were purchased from Enzyme Systems, (Irvine, CA). All other reagents were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise specified.
###end p 54
###begin title 55
PBMC isolation and culture conditions
###end title 55
###begin p 56
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 424 430 <span type="species:ncbi:9913">bovine</span>
Human peripheral blood monocytes were isolated from the heparinized blood of normal donor or buffy coats from the American Red Cross. Normal donor blood samples were obtained after informed written consent as approved by the Ohio State Institutional Review Board. Details provided in online supplement. Isolated monocytes were cultured in a 5-ml polypropylene tube at 10x106 cells/ml in RPMI1640 supplemented with 10% fetal bovine serum (FBS) at 37degreesC in humidified incubator. Typically, cells were stimulated with LPS (1 microg/ml) for indicated time and the cell pellet separated from supernatant by centrifugation at 3000 X g for 5 min.
###end p 56
###begin title 57
Vascular smooth muscle cell culture
###end title 57
###begin p 58
###xml 125 130 <span type="species:ncbi:9606">human</span>
Vascular smooth muscle cells (VSMCs) (passage 3 to 7) were obtained from Clonetics (Biowhitaker, Inc, Walkersville, MD) from human heart donors. VSMC identity was initially confirmed by alpha-smooth muscle actin staining. VSMC initially were grown in growth medium (SmGM2; Clonetics) with 5% FBS, and at 60-70% cell confluence, the media was changed to serum-free medium (50:50 of DMEM/F12 media with 5 ml of ITS, PSA, L-glutamine, and nonessential amino acids per 500 ml of solution). VSMC were co-cultured with either monocytes or conditioned medium from monocytes as per further experiments. Co-culture experiments were performed with RPMI1640 in 10% FBS throughout the experiments.
###end p 58
###begin title 59
Cell death assays
###end title 59
###begin p 60
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Fahy3">[49]</xref>
###xml 457 468 457 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007140.s001">Appendix S1</xref>
VSMC cells were seeded in cell culture plates at a density of 60-70% confluency of cells/well. After overnight incubation with monocytes, conditioned medium or microvesicles from conditioned medium in the presence or absence of inhibitors, VSMC were subjected to cell death analysis. Cell death was identified using light microscopy, Annexin V, caspase-3 activation [49] and crystal violet and LDH assays, as described in details in supplement information (Appendix S1).
###end p 60
###begin title 61
Microvesicle isolation and identification
###end title 61
###begin p 62
Microvesicles were isolated from conditioned medium using ultracentrifugation as described in SI. Isolated microvesicles were characterized using flow cytometry and transmission electron microscopy.
###end p 62
###begin title 63
ELISAs
###end title 63
###begin p 64
###xml 139 150 136 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007140.s001">Appendix S1</xref>
Cytokine levels of IL-1beta and IL-18, as well as caspase-1 levels were measured by sandwich enzyme linked immunoassay (ELISA) (details in Appendix S1).
###end p 64
###begin title 65
Caspase-1 activity
###end title 65
###begin p 66
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 392 396 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Fahy3">[49]</xref>
###xml 397 401 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007140-Wewers2">[51]</xref>
###xml 440 451 426 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007140.s001">Appendix S1</xref>
For caspase-1 activity assay, monocytes were isolated from buffy coats and cultured at a concentration of 10x106 cells/150 microl in 96-well plates. Cells were then stimulated with LPS (5 microg/ml) and supernatants were collected from each well. Cells were spun at 1000gx4degreesC for 10 min to collect the supernatant. Supernatants were then subjected to caspase-1 ELISA or enzymatic assay [49]-[51]. Assay details in supplement section (Appendix S1).
###end p 66
###begin title 67
In-vitro caspase-1 activation
###end title 67
###begin p 68
###xml 81 92 81 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007140.s001">Appendix S1</xref>
In-vitro caspase-1 activation was performed using THP-1 cells as described by in Appendix S1.
###end p 68
###begin title 69
Expression plasmids, cell culture and transfection
###end title 69
###begin p 70
###xml 193 204 193 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007140.s001">Appendix S1</xref>
Caspase-1, ASC plasmids were either created or obtained as gifts. Inhibitors of caspase-1 were purchased. HEK293 cells were cultured and used for transfection of these plasmids. See details in Appendix S1.
###end p 70
###begin title 71
Statistical analysis
###end title 71
###begin p 72
###xml 174 175 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data are represented as the mean +/- standard error of the mean (SEM) from at least three independent experiments. All other simple comparisons were performed with Student's t test, with p<0.05 considered to represent statistical significance.
###end p 72
###begin title 73
Supporting Information
###end title 73
###begin p 74
(0.04 MB DOC)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
The authors thank Dr. Richard Burry for help with TEM and Dr. Tim Eubank for graphic support.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1beta precursor at two distinct sites and does not cleave 31-kDa IL-1alpha.
###end article-title 78
###begin article-title 79
Molecular cloning of the interleukin-1Beta converting enzyme.
###end article-title 79
###begin article-title 80
A novel heterodimeric cysteine protease is required for interleukin-1Beta processing in monocytes.
###end article-title 80
###begin article-title 81
###xml 4 14 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1B-converting enzyme.
###end article-title 81
###begin article-title 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ICE/CED-3 protease nomenclature.
###end article-title 82
###begin article-title 83
The inflammasomes: guardians of the body.
###end article-title 83
###begin article-title 84
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.
###end article-title 84
###begin article-title 85
NOD-like receptors (NLRs): bona fide intracellular microbial sensors.
###end article-title 85
###begin article-title 86
Activation of the native 45-kDa precursor form of interleukin-1- converting enzyme.
###end article-title 86
###begin article-title 87
Caspase activation: the induced-proximity model.
###end article-title 87
###begin article-title 88
Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC.
###end article-title 88
###begin article-title 89
Crystal Structure of Procaspase-1 Zymogen Domain Reveals Insight into Inflammatory Caspase Autoactivation.
###end article-title 89
###begin article-title 90
Pyrin critical to macrophage IL-1b response to Francisella challenge.
###end article-title 90
###begin article-title 91
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 20 26 <span type="species:ncbi:562">E.coli</span>
Caspase-1 regulates E.coli sepsis and splenic B cell apoptosis independently of IL-1beta and IL-18.
###end article-title 91
###begin article-title 92
Salmonella induces macrophage death by caspase-1-dependent necrosis.
###end article-title 92
###begin article-title 93
Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages.
###end article-title 93
###begin article-title 94
Pro-inflammatory programmed cell death.
###end article-title 94
###begin article-title 95
The in and out of monocytes in atherosclerotic plaques: balancing inflammation through migration.
###end article-title 95
###begin article-title 96
###xml 76 81 <span type="species:ncbi:9606">human</span>
Regional accumulation of T cells, macrophage and smooth muscle cells in the human atherosclerotic plaque.
###end article-title 96
###begin article-title 97
Activated monocytes induce smooth muscle cell death: Role of macrophage colony stimulating factor and cell contact.
###end article-title 97
###begin article-title 98
Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage.
###end article-title 98
###begin article-title 99
Membrane microparticle: Two sides of the coin.
###end article-title 99
###begin article-title 100
Microparticles as mediators of cellular cross-talk in inflammatory disease.
###end article-title 100
###begin article-title 101
The role of membrane lipids in the induction of macrophage apoptosis by microparticles.
###end article-title 101
###begin article-title 102
Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles.
###end article-title 102
###begin article-title 103
Histone deacetylase inhibitors prevent exocytosis of interleukin-1b-containing lysosomes: role of microtubules.
###end article-title 103
###begin article-title 104
Rapid secretion of interleukin 1beta by microvesicle shedding.
###end article-title 104
###begin article-title 105
IL-1beta: An exosomal exit.
###end article-title 105
###begin article-title 106
###xml 141 147 <span type="species:ncbi:10090">murine</span>
Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages.
###end article-title 106
###begin article-title 107
Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and release.
###end article-title 107
###begin article-title 108
ICE-like proteases in apoptosis.
###end article-title 108
###begin article-title 109
Caspases: the executioners of apoptosis.
###end article-title 109
###begin article-title 110
Caspases: multifunctional proteases.
###end article-title 110
###begin article-title 111
Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am.
###end article-title 111
###begin article-title 112
Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles.
###end article-title 112
###begin article-title 113
Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
###end article-title 113
###begin article-title 114
###xml 96 106 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
Induction of apoptosis in fibroblasts by IL-1beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.
###end article-title 114
###begin article-title 115
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.
###end article-title 115
###begin article-title 116
Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies.
###end article-title 116
###begin article-title 117
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury.
###end article-title 117
###begin article-title 118
###xml 12 17 <span type="species:ncbi:9606">human</span>
Spontaneous human monocyte apoptosis utilizes a caspase-3 dependent pathway which is blocked by endotoxin and is independent of caspase-1.
###end article-title 118
###begin article-title 119
Prevention of vertebrate neuronal death by the crmA gene.
###end article-title 119
###begin article-title 120
Salmonella rapidly kill dendritic cells via a caspase-1 dependent mechanism.
###end article-title 120
###begin article-title 121
###xml 32 37 <span type="species:ncbi:9606">human</span>
Inflammasome mRNA expression in human monocytes during early septic shock.
###end article-title 121
###begin article-title 122
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
###end article-title 122
###begin article-title 123
The Inflammasome. A molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta.
###end article-title 123
###begin article-title 124
ASC directs NF-kappa B activation by regulating receptor interacting protein-2 (RIP2) caspase-1interactions.
###end article-title 124
###begin article-title 125
RICK/Rip2/CARDIAK mediates signaling for receptors of the innate and adaptive immune systems.
###end article-title 125
###begin article-title 126
###xml 12 17 <span type="species:ncbi:9606">human</span>
Spontaneous human monocyte apoptosis utilizes a caspase-3 dependent pathway which is blocked by endotoxin and is independent of caspase-1.
###end article-title 126
###begin article-title 127
Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10.
###end article-title 127
###begin article-title 128
###xml 63 68 <span type="species:ncbi:9606">human</span>
IL-1 beta converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE dependent.
###end article-title 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 129
###begin p 130
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by AHA fellowship-AHA725557 to AS and NIH grants--HL40871, HL076278 to MDW. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 130

